Evidence map›Paper›PMID 34351705›Full record

ArticleEMBO reports2021

The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder.

Esther Nuebel, Jeffrey T Morgan, Sarah Fogarty, Jacob M Winter, Sandra Lettlova, Jordan A Berg, Yu-Chan Chen, Chelsea U Kidwell, J Alan Maschek, Katie J Clowers and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Mitochondrial membrane remodeling in stress adaptation: Lipid control of organelle quality.Protein science : a publication of the Protein Society · 2026
    Review
  3. Article
  4. Article
  5. Quality control of protein import into mammalian mitochondria.Protein science : a publication of the Protein Society · 2026
    Review
  6. Evolutionary remodeling of a remnant GET pathway factor into PEX38, an essential peroxin.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 3 countries.

Esther NuebelHoward Hughes Medical Institute, Salt Lake City, UT, USA.ORCID 0000-0001-5565-0703
Jeffrey T MorganHoward Hughes Medical Institute, Salt Lake City, UT, USA.ORCID 0000-0002-3017-8665
Sarah FogartyHoward Hughes Medical Institute, Salt Lake City, UT, USA.ORCID 0000-0001-7121-934X
Jacob M WinterDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-7152-183X
Sandra LettlovaDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-5577-4076
Jordan A BergDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-5096-0558
Yu-Chan ChenDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0003-1969-4818
Chelsea U KidwellDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0003-4269-2503
J Alan MaschekDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0003-3217-2299
Katie J ClowersDepartment of Cell Biology, Harvard University School of Medicine, Boston, MA, USA.ORCID 0000-0001-8484-7118
Catherine ArgyriouDepartment of Human Genetics, McGill University, Montreal, ON, Canada.ORCID 0000-0002-3906-0487
Lingxiao ChenDepartment of Pathology, McGill University, Montreal, ON, Canada.ORCID 0000-0001-9118-4834
Ilka WittigFunctional Proteomics, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0002-9751-8054
James E CoxDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-5977-2350
Minna Roh-JohnsonDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0003-3961-4547
Nancy BravermanDepartment of Human Genetics, McGill University, Montreal, ON, Canada.ORCID 0000-0003-1621-5164
Joshua BonkowskyPrimary Children's Hospital, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-8775-147X
Steven P GygiDepartment of Cell Biology, Harvard University School of Medicine, Boston, MA, USA.ORCID 0000-0001-7626-0034
Jared RutterHoward Hughes Medical Institute, Salt Lake City, UT, USA.ORCID 0000-0002-2710-9765
University of Utah · USHoward Hughes Medical Institute · USHarvard University · USMcGill University · CAGoethe University Frankfurt · DEMcGill University Health Centre · CAPrimary Children's Hospital · US

Funding

Proteomics CoreU54DK110858 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, JAMES Eric COX · 2016 to 2026
$8.6M
Mitochondrial Biochemistry: From Mechanisms to DiseaseR35GM131854 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 2019 to 2026
$3.3M
Mitochondrial lateral transfer during metastasisR37CA247994 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Minna Roh · 2021 to 2026
$2.4M
Msp1/ATAD1: mitochondrial and peroxisomal protein sortingR01GM115174 · NIGMS · UNIVERSITY OF UTAH · PI RUTTER, JARED P · 2015 to 2018
$1.0M
Agilent 6550 QTOF system for U of UtahS10OD016232 · OD · UNIVERSITY OF UTAH · PI COX, JAMES ERIC · 2013 to 2013
$578k
Agilent 7200 GC/Q-TOF for the University of UtahS10OD021505 · OD · UNIVERSITY OF UTAH · PI COX, JAMES ERIC · 2016 to 2016
$401k
Mitochondrial quality control as a selective vulnerability in cancers with chromosome 10q deletionF30CA243440 · NCI · UNIVERSITY OF UTAH · PI WINTER, JACOB MICHAEL · 2020 to 2024
$189k
Contextualizing Chaotic Metabolic Networks and Their RegulationF99CA253744 · NCI · UNIVERSITY OF UTAH · PI BERG, JORDAN ALEXANDER · 2020 to 2021
$73k
CIHR 34575Howard Hughes Medical InstituteNCI NIH HHS F30 CA243440NCI NIH HHS F99 CA253744NCI NIH HHS R37 CA247994NIDDK NIH HHS U54 DK110858NIGMS NIH HHS R01 GM115174NIGMS NIH HHS R35 GM131854NIH HHS S10 OD016232NIH HHS S10 OD021505
6 · The paper itself

Abstract

Peroxisomal biogenesis disorders (PBDs) are genetic disorders of peroxisome biogenesis and metabolism that are characterized by profound developmental and neurological phenotypes. The most severe class of PBDs-Zellweger spectrum disorder (ZSD)-is caused by mutations in peroxin genes that result in both non-functional peroxisomes and mitochondrial dysfunction. It is unclear, however, how defective peroxisomes contribute to mitochondrial impairment. In order to understand the molecular basis of this inter-organellar relationship, we investigated the fate of peroxisomal mRNAs and proteins in ZSD model systems. We found that peroxins were still expressed and a subset of them accumulated on the mitochondrial membrane, which resulted in gross mitochondrial abnormalities and impaired mitochondrial metabolic function. We showed that overexpression of ATAD1, a mitochondrial quality control factor, was sufficient to rescue several aspects of mitochondrial function in human ZSD fibroblasts. Together, these data suggest that aberrant peroxisomal protein localization is necessary and sufficient for the devastating mitochondrial morphological and metabolic phenotypes in ZSDs.

Indexed as

Peroxisomal DisordersZellweger SyndromeHumansMitochondriaPeroxinsPeroxisomesPeroxinsmitochondriamitochondrial quality controlperoxisomal biogenesis disorderperoxisomal importperoxisomes

Identifiers

PMID34351705
PMCPMC8490991
OpenAlexW3189405174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.